B.R.I.D.G.E. TO DATA®
"Kidz with Leukemia: A Space Adventure"
"Conquering Cancer Network"
The Degge Group, Ltd. provides consulting services in pharmacoepidemiology, risk management, clinical drug safety, and pharmacovigilance to the pharmaceutical and medical product sector.
Degge's staff has contributed to the burgeoning fields of pharmacoepidemiology and pharmacovigilance for over two decades and has worked to enhance the understanding of drug safety, drug use, natural history of disease, pharmacoeconomic and outcomes research, and recently risk evaluation and mitigation strategies (REMS).
Degge will help you identify and analyze key factors and find the right solution.
Earl Goehring Jr. will be attending the ISPOR 18th Annual International Meeting, May 20-23, 2013, in New Orleans, LA.
He will also be representing DGI and therefore available to discuss their Poster titled "Spontaneous Reporting Data: A Global Comparison Using An Online Database Resource" (PRM68) on Monday, May 20, 2013, between 1:15 PM and 2:15 PM CT (Poster Session 1). The poster will be on display between 8:30 AM and 2:15 PM CT. For more information on the poster, please contact email@example.com.
Congratulations to Dawn Kim-Romo for being awarded the PhRMA Foundation's Pre-Doctoral Fellowship in Health Outcomes. Dawn was a star intern at The Degge Group, Ltd. in the Summer of 2012, and she is currently a PhD candidate at the University of Texas, Austin (as well as a practicing pharmacist). We take no credit for Dawn's success, but are simply proud to be associated with such a motivated professional!
Degge' formal internship program has had the good fortune to train graduate and professional students in pharmacoepidemiology and drug safety for nearly 10 years.
Here's more info on our internship.
Degge presented a poster at the American College of Cardiology's 62nd Annual Scientific Session & Expo in San Francisco, CA, March 9-11, 2013.
Goehring Jr EL, Bohn RL, Pezzullo JC, Jones JK. Real-world Outcomes for Dronedarone Initiators Compared to Other Antiarrhythmic Agents in the Treatment of Atrial Fibrillation in a Large United States Population. J Am Coll Cardiol. 2013;61(10_S): doi:10.1016/S0735-1097(13)60269-7
[ PDF ]
The Degge Group, Ltd.
clinical drug safety, pharmacovigilance, and pharmacoepidemiology since 1988.
1616 North Fort Myer Drive, Suite 1430
Arlington, Virginia 22209 USA
1 (888) 413-3443
Phone: +1 (703) 276-0067 || Fax: +1 (703) 276-0069